Cart
sales@molnova.com
TGP-377/421
CAS No. 16752-89-9
TGP-377/421( —— )
Catalog No. M35508 CAS No. 16752-89-9
TGP-377/421 (Targapre-miR-377/421) is a potent dual inhibitor that binds to and inhibits miR-377 and miR-421 at their functional sites.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 154 | In Stock |
|
| 5MG | 140 | In Stock |
|
| 10MG | 227 | In Stock |
|
| 25MG | 454 | In Stock |
|
| 50MG | 718 | In Stock |
|
| 100MG | 1004 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2009 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTGP-377/421
-
NoteResearch use only, not for human use.
-
Brief DescriptionTGP-377/421 (Targapre-miR-377/421) is a potent dual inhibitor that binds to and inhibits miR-377 and miR-421 at their functional sites.
-
DescriptionTGP-377/421 (Targapre-miR-377/421) is a potent miR-377 and miR-421 inhibitor that binds a functional site in both miRNAs.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16752-89-9
-
Formula Weight340.38
-
Molecular FormulaC20H16N6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 66.67 mg/mL (195.87 mM; Ultrasonic )
-
SMILESNc1ccc2[nH]c(nc2c1)-c1cccc(c1)-c1nc2cc(N)ccc2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Haniff HS, et al. Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions. Nat Chem. 2020 Oct;12(10):952-961. ?
molnova catalog
related products
-
[D-Arg0,Hyp3,D-Phe7]...
NPC-567 is a bradykinin B2 receptor antagonist. NPC-567 is effective in inhibiting the acute response to allergen in the airways.
-
Chrysin 7-O-beta-gen...
Chrysin 7-O-beta-gentiobioside, a glycosylation product of Chrysin, is from Spartium junceum.
-
Dooku1
Dooku1 is an analog of Yoda1 and a selective antagonist of endogenous Piezo1 channels.
